Predictive Technology Group Inc
OTC:PRED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Predictive Technology Group Inc
Long-Term Investments
Predictive Technology Group Inc
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Predictive Technology Group Inc
OTC:PRED
|
Long-Term Investments
$12.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Long-Term Investments
$268m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Long-Term Investments
$3B
|
CAGR 3-Years
34%
|
CAGR 5-Years
43%
|
CAGR 10-Years
-13%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Long-Term Investments
$5.7B
|
CAGR 3-Years
287%
|
CAGR 5-Years
207%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Long-Term Investments
$10.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
Predictive Technology Group Inc
Glance View
Predictive Technology Group, Inc. engages in the development and commercialization of discoveries and technologies involved in novel molecular diagnostic and pharmaceutical therapeutic and human cells, tissues, and human cellular and tissue-based products. The company is headquartered in Salt Lake City, Utah and currently employs 62 full-time employees. The company went IPO on 2007-07-11. The firm operates through two segments: Human Cell and Tissues Products (HCT/Ps) and diagnostics and therapeutics. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The firm's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. The company offers genetic tests through a number of Advanced Reproductive Technologies (ART) clinics.The Company’s tests include ARTguide and FertilityDX. The RTguide test is a genetic test for women experiencing infertility and other genetic condition.
See Also
What is Predictive Technology Group Inc's Long-Term Investments?
Long-Term Investments
12.7m
USD
Based on the financial report for Jun 30, 2020, Predictive Technology Group Inc's Long-Term Investments amounts to 12.7m USD.
What is Predictive Technology Group Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-8%
Over the last year, the Long-Term Investments growth was -75%. The average annual Long-Term Investments growth rates for Predictive Technology Group Inc have been -8% over the past three years .
